MedPath

THE HIV NETHERLANDS AUSTRALIA THAILAND RESEARCH COLLABORATION

🇹🇭Thailand
Ownership
Private
Employees
-
Market Cap
-
Website

Pharmacokinetics of Low Dose Ritonavir

Phase 1
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2008-02-22
Last Posted Date
2012-04-05
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
20
Registration Number
NCT00622206
Locations
🇹🇭

HIV-NAT, Bangkok, Thailand

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Phase 2
Completed
Conditions
HIV Infections
Interventions
Drug: generic lopinavir/ritonavir
First Posted Date
2008-02-22
Last Posted Date
2020-07-17
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
20
Registration Number
NCT00621166
Locations
🇹🇭

Department of Obsterics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy

Completed
Conditions
HIV Infections
First Posted Date
2007-08-03
Last Posted Date
2020-07-17
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
700
Registration Number
NCT00511056
Locations
🇹🇭

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs

Not Applicable
Completed
Conditions
HIV Infections
Interventions
Procedure: salvage therapy
First Posted Date
2007-05-23
Last Posted Date
2020-07-17
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
95
Registration Number
NCT00477308
Locations
🇹🇭

Chulalongkorn Hospital, Bangkok, Thailand

🇹🇭

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand

🇹🇭

Queen Sirikit National Institute of Child Health, Bangkok, Bangkok, Thailand

A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects

Phase 2
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2007-05-22
Last Posted Date
2020-07-17
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
28
Registration Number
NCT00476424
Locations
🇹🇭

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand

A Prospective Cohort of Children With HIV Infection

Active, not recruiting
Conditions
HIV Infections
Interventions
Drug: Zidovudine, Stavudine, Didanosine, Lamivudine
Drug: Nevirapine, Efavirenz
Drug: LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir
First Posted Date
2007-05-22
Last Posted Date
2024-02-28
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
500
Registration Number
NCT00476606
Locations
🇹🇭

HIV-NAT, Bangkok, Thailand

🇹🇭

Pediatric infectious diseases section, Chulalongkorn University, Bangkok, Thailand

🇹🇭

Khon Kaen University, Khon Kaen, Thailand

Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: GPO ritonavir versus Norvir
First Posted Date
2007-05-22
Last Posted Date
2012-04-05
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
16
Registration Number
NCT00477126
Locations
🇹🇭

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand

Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r

Completed
Conditions
HIV Infections
Interventions
Genetic: identify genetic polymorphism in Thai HIV infected
First Posted Date
2007-05-22
Last Posted Date
2012-04-05
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
250
Registration Number
NCT00476502
Locations
🇹🇭

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

Phase 2
Completed
Conditions
IDV Associated Nephrotoxicity
Interventions
First Posted Date
2007-05-22
Last Posted Date
2016-02-22
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
30
Registration Number
NCT00477048
Locations
🇹🇭

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

Phase 2
Completed
Conditions
Hepatitis B Virus
HIV Infections
Interventions
First Posted Date
2007-05-22
Last Posted Date
2016-02-22
Lead Sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Target Recruit Count
24
Registration Number
NCT00476463
Locations
🇹🇭

HIV-NAT Thai Red Cross AIDS Research Center, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath